PHAMALy highlighted on NewsHour
Kathleen Traylor, with Educational Support Services, is one of the
founders of the Physically Handicapped Amateur Musical Actors League, Inc.
(PHAMALy), a Denver theater troupe that employs actors with mental and
physical disabilities.
The troupe was recently highlighted on the NewsHour
(http://www.pbs.org/newshour/bb/entertainment/july-dec06/theater_08-29.html).
Traylor, who played Auntie Em in the recent production of "The Wiz," said
it all started on a whim, when five disabled friends applied for a grant
from a local arts council in 1989 – and they received $3,300.They started
with “Guys and Dolls” in 1990, and have been ‘on stage’ ever
since.
The mission of PHAMALy is to enable persons with disabilities to showcase
their talents and abilities through live productions and to make the performing
arts more accessible to everyone.
For more information about PHAMALy, go to http://www.phamaly.org/about.html.
Dr. Ann Thor appointed chair of national pathology committee
Ann Thor, MD, has been named chair of the Cancer and Leukemia Group
B (CALGB) Pathology Committee. Thor has been serving as the committee vice-chair
for the last few years.
Thor is a translational scientist who has made important contributions
to science’s understanding of breast cancer biology, in particular,
the role of Her2/neu as a determinant of prognosis and treatment response.
She is chair of the Department of Pathology at UCD.
As chair of the Pathology Committee, Thor will also serve as a member
of the CALGB Board of Directors, and will co-chair a recently appointed Biospecimens
and Correlative Science Advisory Committee in CALGB.
Employees of the Month
Phillip Villa, assistant engineer
in the Office of Real Estate and Facilities, was named Employee of
the Month for July.
“ Phil goes above and beyond and follows up on calls of building maintenance
issues to assure the requester is happy and repairs are done in a timely manner,” said
Claudette Iacina, a coworker.
“ He has a positive attitude and great sense of humor and works so hard,” said
Alysa Sherman, a coworker.
Dawn Rohr, a general professional II with the School of Nursing,
was named Employee of the Month for August.
“ Dawn exemplifies commitment to the academic programs of the School of
Nursing (SON) far beyond her formal job description,” said Lauren Clark,
RN, PhD, FAAN, associate dean for Research Affairs at the SON.
“This kind
of dedication is something that can't be bought! And, I'm not sure how to explain
what "delightfulness" means in Dawn's case, but it's the best word
I can think of to capture her sense of humor, her quick smile, her thoughtful
consideration, and her easy way with people. Overall, she's a ‘10’ on
the delightfulness scale.”
“ In addition to all of her amazing skills at managing her office, she
is always willing to lend a hand with other tasks,” said Karen Marks, executive
assistant to the dean at the SON. “She quietly does her job, knows where
everything is, works extremely hard, never complains and never makes you feel
like she is too busy to help.”
UCD School of Nursing appoints new associate dean
Joan K. (Kathy) Magilvy, PhD, RN, FAAN, has been appointed associate
dean for academic programs at the University of Colorado Denver School of Nursing.
 |
| Joan K. (Kathy) Magilvy, PhD, RN, FAAN |
Magilvy has been a professor at the School of Nursing for 24 years.
She served most recently as assistant dean for graduate programs and director
of the PhD program. Her new appointment became effective Aug. 1.
“Kathy is an accomplished researcher in community, rural and public health
nursing, cross-cultural aging, and long-term care. She has expertise in community-based
health services for older people and those with chronic illness and disability,” said
Pat Moritz, PhD, RN, FAAN, dean of the UCD School of Nursing. “Her considerable
experience as an educator, researcher and administrator are greatly valued and
appreciated.”
In her new role, Magilvy will continue to direct the school’s PhD program,
and will be senior administrator for its undergraduate and graduate programs.
A noted expert in qualitative and ethnographic methodologies, Magilvy has received
funding from the National Institutes of Health (NIH) and other federal agencies
for her studies during the past two decades.
Within nursing and gerontology, Magilvy has received numerous regional and national
awards, including the Nightingale and Shannon Mentor awards, and has been inducted
as a fellow into the American and Western academies of nursing.
Magilvy succeeds Marlaine Smith, RN, PhD, FAAN, who resigned to accept the endowed
chair in caring science at Florida Atlantic University.
Pepper Schedin to receive
award for abstract
Pepper Schedin, PhD, has had her abstract titled Microenvironment of the
Involuting Mammary Gland Activates Tumor Metastasis selected as best abstract award for
the 25th Congress of the International Association for Breast Cancer Research.
Schedin is an associate professor of medicine, Division of Medical Oncology
at the University of Colorado Denver Cancer Center
The awards presentation will take place Sept. 18, at which time Schedin will
receive a certificate from Roche Pharmaceuticals.
Choon-Kee Lee brings myeloma expertise to cancer center
When others said “nothing can be done,” Choon-Kee Lee, MD, thought
otherwise. As a result, during his first year practicing medicine in South Korea,
he saved seven people who were pronounced dead before they even entered the hospital.
 |
| Choon-Kee Lee, MD |
“
I always strive to give the best patient care,” Lee explained. “When
nothing can be done based on what we have available to us now, we have to
look for other options.”
This way of thinking is what drove Lee to specialize in cancer, specifically
myeloma. Although new and better treatments have increased survival for people
diagnosed with myeloma, there is no cure.
“
We have an obligation to extend survival much longer and achieve a cure,” he
said. “The only thing that enables us to do that is clinical investigations.
That is a critical component of academic institutions like the University
of Colorado Cancer Center, and one of the reasons I came here.”
Lee recently joined UCCC because of the opportunity to introduce new treatment
options through clinical trials. He will serve as the director of the Myeloma
Program of the Hematologic Malignancies and Blood and Marrow Transplant Program.
| The Multiple Myeloma Research Foundation’s definition
of multiple myeloma: Multiple myeloma, a cancer of the plasma cell, is an incurable but treatable disease. While a myeloma diagnosis can be overwhelming, it is important to remember that there are several promising new therapies that are helping patients live longer, healthier lives. The estimated frequency of multiple myeloma is five to six new cases per 100,000 persons per year. At present there are more than 50,000 people in the United States living with multiple myeloma. |
His academic career began at the Blood and Marrow Transplant Program of the
University of Iowa in 1992. He has outstanding expertise in the care of patients
with myeloma
through his extensive experiences at the Myeloma Institute for Research and
Therapy in Little Rock as clinical investigator and director of the Allogeneic
Transplant
Program from 2001 to 2005.
The Myeloma Institute, where 90 percent of myeloma
therapies have been discovered, gave him important experience conducting clinical
trials for myeloma.
Although his research contributions to the understanding of the various aspects
of myeloma and blood and marrow transplant have been exceptional and well-known
among his colleagues in the myeloma community, he is most proud of providing
good care for his patients and their families.
“
My mentor at Iowa taught me that physicians must be sensitive with patients,” he
explained. “As a result, I treat patients and their family members
with sensitivity, while also giving them the best therapies that science
can offer.”
He went on to explain that clinical researchers bring science to the clinic. “When
a patient and their physician think they have run out of options, academic
centers can provide what is new in science.”
With the ongoing discovery of new small molecules and better understanding
of apoptosis biology (how cancer cells die and survive) and genetics, he plans
to
initiate several clinical studies that will ultimately help patients achieve
long-lasting responses. After only a couple of months at UCCC, Lee already
has five new clinical trial protocols under review that he anticipates will
be available
to patients soon.
To contact the Myeloma Program, call 720-848-0300.
In memoriam
Dr. Ray Kilcoyne, a renowned radiologist at the University of Colorado Denver, died Aug. 8 at age 69 after a short illness.
Kilcoyne
moved to Colorado almost 15 years ago, and, though retired, still put in hours
at the hospital doing the work he loved. He also enjoyed model railroad trains
and rebuilding old cars.
His wife of nearly 30 years, Claire Kilcoyne, AuD, is an audiologist in practice
at Audiology and Balance Center in Denver.
A scholarship has been established in Kilcoyne’s name through the Audiology
Foundation of America (AFA), a non-profit organization founded in 1989 to lead
audiology’s transition to a doctoring profession with the AuD, as its
unique designator. The scholarship will help pay for the education of a future
Doctor
of Audiology (AuD).
Contributions to this scholarship fund are being accepted by the AFA, 8 North
Third St., Suite 406, Lafayette, Ind., 47901. For information about AFA, visit
the web site at www.audfound.org
Archives |
|
Awards & Recognition |
News |
